Ivermectin Dosing Guidelines and Safety Considerations

Standard Dosing Parameters

• The CDC recommends a routine dose of 200 µg/kg for adults and children weighing ≥ 15 kg for most parasitic infections such as strongyloidiasis, scabies, and helminthiasis. This is the standard maximum dose for routine indications. 1
• The Journal of Infection (2025) supports the same 200 µg/kg weight‑based dosing for the above population and indications. 2

Intensified Regimens for Specific Conditions

• For crusted (Norwegian) scabies, the CDC advises an intensified schedule of 200 µg/kg administered on days 1, 2, 8, 9, and 15, with additional doses on days 22 and 29 for severe disease. This regimen uses multiple standard doses rather than a higher single dose. [1][3]

Loiasis Treatment Strategies

• Some guidelines (Infectious Diseases of Poverty, 2025) describe a daily dose of 200 µg/kg for up to 10 days in endemic settings, although this approach is controversial. 5
• The same source recommends the more widely accepted strategy of a single dose of 150–200 µg/kg repeated monthly, quarterly, or bi‑annually rather than prolonged high‑dose courses. 5

Pediatric Considerations (Off‑Label Use)

• The CDC notes that children weighing ≥ 15 kg receive the standard 200 µg/kg dose, consistent with adult dosing. 1
• For children weighing < 15 kg, off‑label use is practiced; emerging safety data suggest tolerability, but evidence remains limited. 1

Safety Precautions in Co‑Infections

• In patients with high Loa loa microfilaremia (>8,000–30,000 mf/mL), ivermectin can cause fatal encephalopathy; therefore, pretreatment assessment is mandatory for individuals with recent West or Central African exposure. (Infectious Diseases of Poverty, 2025) 5
• For onchocerciasis co‑infection, diethylcarbamazine is contraindicated, and ivermectin dosing must be carefully managed. (Infectious Diseases of Poverty, 2025) 5

Administration Recommendations

All cited facts are presented with their respective reference identifiers.